These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34472523)

  • 1. Utility of various inflammatory markers in predicting outcomes of hospitalized patients with COVID-19 pneumonia: A single-center experience.
    Marimuthu AK; Anandhan M; Sundararajan L; Chandrasekaran J; Ramakrishnan B
    Lung India; 2021; 38(5):448-453. PubMed ID: 34472523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation?
    Vaira LA; De Vito A; Deiana G; Pes C; Giovanditto F; Fiore V; Lechien JR; Saussez S; Policicchio D; Boccaletti R; Madeddu G; Babudieri S; Pazzola A; Bandiera F; Fois AG; Piana AF; Hopkins C; De Riu G
    J Laryngol Otol; 2021 Aug; 135(8):723-728. PubMed ID: 34184623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil to lymphocytic ratio and other inflammatory markers as adverse outcome predictor in hospitalized COVID-19 patients.
    Abdelhady SA; Rageh F; Ahmed SS; Al-Touny SA; Riad E; Elhoseeny MM; Khalifa AA; Salim A; Farghly MI; Elgamal R
    Egypt J Immunol; 2022 Apr; 29(2):57-67. PubMed ID: 35436055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience.
    Farid E; Sridharan K; Alsegai OA; Khawaja SA; Mansoor EJ; Teraifi NA; Qahtani MA; Salman JA
    Biomark Med; 2021 Jun; 15(8):541-549. PubMed ID: 33988463
    [No Abstract]   [Full Text] [Related]  

  • 5. The Evaluation of Laboratory Parameters as Predictors of Disease Severity and Mortality in COVID-19 Patients: A Retrospective Study From a Tertiary Care Hospital in India.
    Dwivedi T; Raj A; Das N; Gupta R; Gupta N; Tiwari P; Sahoo B; Sagiraju HKR; Sirohiya P; Ratre B; Elavarasi A; Mohan A; Bhatnagar S
    Cureus; 2023 Jun; 15(6):e40273. PubMed ID: 37448393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
    Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
    Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poor Prognostic Biochemical Markers Predicting Fatalities Caused by COVID-19: A Retrospective Observational Study From a Developing Country.
    Asghar MS; Haider Kazmi SJ; Khan NA; Akram M; Hassan M; Rasheed U; Ahmed Khan S
    Cureus; 2020 Aug; 12(8):e9575. PubMed ID: 32913691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Inflammatory Markers With Disease Progression and the Severity of COVID-19.
    Patel SV; Pathak JM; Parikh RJ; Pandya KJ; Kothari PB; Patel A
    Cureus; 2024 Feb; 16(2):e54840. PubMed ID: 38533136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences of inflammatory and non-inflammatory indicators in Coronavirus disease-19 (COVID-19) with different severity.
    Wang M; Zhu Q; Fu J; Liu L; Xiao M; Du Y
    Infect Genet Evol; 2020 Nov; 85():104511. PubMed ID: 32858231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study.
    Pan F; Yang L; Li Y; Liang B; Li L; Ye T; Li L; Liu D; Gui S; Hu Y; Zheng C
    Int J Med Sci; 2020; 17(9):1281-1292. PubMed ID: 32547323
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlation of refractory hypoxemia with biochemical markers and clinical outcomes of COVID-19 patients in a developing country: A retrospective observational study: Running head: Predictors of hypoxemia in COVID-19.
    Asghar MS; Ahmed I; Alvi H; Iqbal S; Khan I; Alvi RS; Saeed Z; Irfan S; Akhtar M; Fatima I
    J Community Hosp Intern Med Perspect; 2021 Jan; 11(1):9-16. PubMed ID: 33552406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Sequentially Monitored Laboratory Values and Inflammatory Biomarkers in Assessing the Severity of COVID-19.
    Baran B; Yetkin NA; Tutar N; Türe Z; Oymak FS; Gülmez İ
    Cureus; 2024 Jan; 16(1):e51458. PubMed ID: 38298278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of Computed Tomography (CT) Severity Score With Laboratory and Clinical Parameters and Outcomes in Coronavirus Disease 2019 (COVID-19).
    Pamulapati BK; Nanjundappa RK; Chandrabhatla BS; Roohi SU; Palepu S
    Cureus; 2024 Jan; 16(1):e52324. PubMed ID: 38361692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Biochemical Markers in Invasive Ventilation of Coronavirus Disease 2019 Patients: Multinomial Regression and Survival Analysis.
    Asghar MS; Haider Kazmi SJ; Khan NA; Akram M; Jawed R; Rafaey W; Hassan M; Rasheed U; Khan M; Khan AR
    Cureus; 2020 Aug; 12(8):e10054. PubMed ID: 32999777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of routine laboratory tests to predict mortality and deterioration to severe or critical COVID-19 in people with SARS-CoV-2.
    De Rop L; Bos DA; Stegeman I; Holtman G; Ochodo EA; Spijker R; Otieno JA; Alkhlaileh F; Deeks JJ; Dinnes J; Van den Bruel A; McInnes MD; Leeflang MM; ; Verbakel JY
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD015050. PubMed ID: 39105481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity and prognostic factors of SARS-CoV-2-induced pneumonia: The value of clinical and laboratory biomarkers and the A-DROP score.
    Szabó M; Kardos Z; Oláh C; Tamáska P; Hodosi K; Csánky E; Szekanecz Z
    Front Med (Lausanne); 2022; 9():920016. PubMed ID: 35935801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the association between inflammatory markers and the prognosis of Covid-19.
    Manjili DA; Mohammadnia-Afrozi M; Rostami A; Babaei FN; Bayani M
    J Family Med Prim Care; 2023 Oct; 12(10):2274-2281. PubMed ID: 38074254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Immune-inflammatory markers & clinical characteristics for outcomes in hospitalized SARS-CoV-2 infected patients of Pakistan: a retrospective analysis'.
    Khalid A; Aqeel RF; Nawaz A; Ahmad J; Fatima ST; Shahid S; Rao AA; Aktas G; Ijaz S; Shehryar M
    Hematology; 2023 Dec; 28(1):2199629. PubMed ID: 37408482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying the Probable Etiology of Acute Undifferentiated Fever through Inflammatory Markers.
    Govindaraj V; Poonia D; Bhardwaj G; Balasubramani S; Michael B
    J Assoc Physicians India; 2024 May; 72(5):13-16. PubMed ID: 38881103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.